Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy MEI Pharma stock

Learn how to easily invest in MEI Pharma stock.

MEI Pharma Inc is a biotechnology business based in the US. MEI Pharma shares (MEIP) are listed on the NASDAQ and all prices are listed in US Dollars. MEI Pharma employs 102 staff and has a trailing 12-month revenue of around $40.7 million.

How to buy shares in MEI Pharma

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – MEIP – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

MEI Pharma stock price (NASDAQ: MEIP)

Use our graph to track the performance of MEIP stocks over time.

MEI Pharma shares at a glance

Information last updated 2022-09-25.
Latest market close$0.40
52-week range$0.41 - $3.55
50-day moving average $0.51
200-day moving average $1.15
Wall St. target price$5.17
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.52

Buy MEI Pharma shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 8 of 8
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Ally Invest Self-Directed Trading
Stocks, Bonds, Options, Mutual funds, ETFs
when you deposit or transfer $10,000–$24,900
500+ commission-free ETFs, some of the industry's lowest fees plus a cash bonus up to $3,000.
Stocks, Options, ETFs
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy MEI Pharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

MEI Pharma price performance over time

Historical closes compared with the close of $0.4 from 2022-09-26

1 week (2022-09-20) -9.09%
1 month (2022-08-26) -24.53%
3 months (2022-06-27) -38.46%
6 months (2022-03-23) N/A
1 year (2021-09-27) -86.35%
2 years (2020-09-25) -87.18%
3 years (2019-09-27) 1.7
5 years (2017-09-27) 2.73

Is MEI Pharma stock undervalued or overvalued?

Valuing MEI Pharma stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of MEI Pharma's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

MEI Pharma's PEG ratio

MEI Pharma's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 20.6. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into MEI Pharma's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

MEI Pharma financials

Revenue TTM $40.7 million
Gross profit TTM $40.7 million
Return on assets TTM -26.81%
Return on equity TTM -106.9%
Profit margin -133.8%
Book value $0.39
Market capitalisation $55.3 million

TTM: trailing 12 months

MEI Pharma share dividends

We're not expecting MEI Pharma to pay a dividend over the next 12 months.

Have MEI Pharma's shares ever split?

MEI Pharma's shares were split on a 1:6 basis on 18 December 2012. So if you had owned 6 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your MEI Pharma shares – just the quantity. However, indirectly, the new 500% higher share price could have impacted the market appetite for MEI Pharma shares which in turn could have impacted MEI Pharma's share price.

MEI Pharma share price volatility

Over the last 12 months, MEI Pharma's shares have ranged in value from as little as $0.41 up to $3.55. A popular way to gauge a stock's volatility is its "beta".

MEIP.US volatility(beta: 0.81)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while MEI Pharma's is 0.809. This would suggest that MEI Pharma's shares are less volatile than average (for this exchange).

MEI Pharma overview

MEI Pharma, Inc. , a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymphoma, as well as in Phase Ib multi-arm trial to treat B-cell malignancies; and Voruciclib, an oral cyclin-dependent kinase 9 inhibitor, which is in Phase Ib clinical trial for acute myeloid leukemia and B-cell malignancies. It also develops ME-344, a mitochondrial inhibitor targeting the oxidative phosphorylation complex that is in Phase I clinical trial for the treatment of human epidermal growth factor receptor 2 negative breast cancer; and Pracinostat, an oral available histone deacetylase inhibitor, which is in Phase II clinical trial to treat patients with myelodysplastic syndrome. MEI Pharma, Inc. has a license, development, and commercialization agreement with Kyowa Kirin Company; a clinical collaboration with BeiGene, Ltd. ; a license, development, manufacturing, and commercialization agreement with Helsinn Healthcare SA; and a license agreement with Presage Biosciences, Inc.

Frequently asked questions

What percentage of MEI Pharma is owned by insiders or institutions?
Currently 0.491% of MEI Pharma shares are held by insiders and 38.002% by institutions.
How many people work for MEI Pharma?
Latest data suggests 102 work at MEI Pharma.
When does the fiscal year end for MEI Pharma?
MEI Pharma's fiscal year ends in June.
Where is MEI Pharma based?
MEI Pharma's address is: 11455 El Camino Real, San Diego, CA, United States, 92130
What is MEI Pharma's ISIN number?
MEI Pharma's international securities identification number is: US55279B2025
What is MEI Pharma's CUSIP number?
MEI Pharma's Committee on Uniform Securities Identification Procedures number is: 55279B103

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site